echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Anesthesia Topics > JAMA Subjournal: These 3 points are crucial about the reduction of buprenorphine for the treatment of opioid use disorder!

    JAMA Subjournal: These 3 points are crucial about the reduction of buprenorphine for the treatment of opioid use disorder!

    • Last Update: 2022-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    North America is facing a devastating opioid abuse crisis, with more than 6,300 opioid overdose deaths in Canada in 2020 and more than 90,000 deaths from opioid abuse


    Although most clinical guidelines recommend indefinite continued treatment, retention of MOUD is low


    Therefore, the purpose of this study was to determine the prescription characteristics of opioid overdose after buprenorphine tapering, and to understand how to safely tape buprenorphine is an important, patient-centered issue that could have significant implications


    This population-based retrospective cohort study was conducted in adults


    The results showed that among 5774 individuals, the median (IQR) age was 34 years old (28-44 years), of which 3462 (60.


    Overall, in this retrospective cohort study, buprenorphine was tapered at least 1 year after treatment, with a slower rate of tapering and a lower percentage of days of dose reduction, regardless of the duration of the tapering, all associated


    Original source:

    Bozinoff N, Men S, Kurdyak P, Selby P, Gomes T.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.